Anti-swine flu vaccination linked to increased risk of narcolepsy in young adults

Pandemrix is an influenza vaccination, created in 2009 to combat H1N1, known as Swine Flu. Now, a team of Swedish clinicians testing the vaccine for links to immune-related or neurological diseases have linked Pandemrix to an increased risk of narcolepsy in young adults.

Using a population-based prospective cohort study, the team analyzed data from regional vaccination registries and national health registries, covering seven healthcare regions and 61% of the Swedish population.

While the team did not identify any link to a large number of immune-related or , they did confirm an increased risk in diagnosis of narcolepsy in individuals younger than 20 years of age, and observed a trend towards an increased risk amongst young adults between 21 and 30.

"The follow-up of Pandemrix vaccinations in a large registry based study in Sweden confirms an increased risk of narcolepsy in children and adolescents, while also providing reassuring results for a large number of other neurological and immune related diseases," said Dr. I. Persson from the Karolinska Institutet, Stockholm.


Explore further

Flu vaccine also linked to narcolepsy in adults, study reports

More information: I. Persson, F. Granath, J. Askling, J. F. Ludvigsson, T. Olsson, N. Feltelius, 'Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up', Journal of Internal Medicine, DOI: 10.1111/joim.1215
Journal information: Journal of Internal Medicine

Provided by Wiley
Citation: Anti-swine flu vaccination linked to increased risk of narcolepsy in young adults (2014, January 21) retrieved 23 October 2021 from https://medicalxpress.com/news/2014-01-anti-swine-flu-vaccination-linked-narcolepsy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors